Accelerating drug development for simple and complex drug programmes
When it comes to complex drug programmes, the challenges in achieving clinical and commercial success are even greater.
List view / Grid view
When it comes to complex drug programmes, the challenges in achieving clinical and commercial success are even greater.
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...